Oxford BioMedica plc Share Price London S.E.
Equities
GB0006648157_GB
GB0006648157
Biotechnology & Medical Research
Sales 2023 | 89.54M 112M 8.95B | Sales 2024 * | 130M 163M 12.99B | Capitalization | 287M 360M 28.7B |
---|---|---|---|---|---|
Net income 2023 | -157M -197M -15.7B | Net income 2024 * | -35M -43.87M -3.5B | EV / Sales 2023 | 2.38 x |
Net cash position 2023 * | 49.23M 61.7M 4.92B | Net cash position 2024 * | 13.8M 17.3M 1.38B | EV / Sales 2024 * | 2.1 x |
P/E ratio 2023 |
-1.35
x | P/E ratio 2024 * |
-8.39
x | Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 80.81% |
Latest transcript on Oxford BioMedica plc
Managers | Title | Age | Since |
---|---|---|---|
Frank Mathias
CEO | Chief Executive Officer | 62 | 26/03/23 |
Stuart Paynter
DFI | Director of Finance/CFO | 52 | 28/08/17 |
Chairman | 68 | 23/06/20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Leone Patterson
BRD | Director/Board Member | 61 | 30/04/23 |
Chairman | 68 | 23/06/20 | |
Stuart Henderson
BRD | Director/Board Member | 66 | 31/05/16 |
1st Jan change | Capi. | |
---|---|---|
-1.17% | 102B | |
+2.87% | 96.09B | |
+2.13% | 22.28B | |
-14.77% | 21.4B | |
-8.79% | 18.14B | |
-39.98% | 17.02B | |
-13.21% | 16.09B | |
+8.55% | 13.83B | |
+35.75% | 11.97B |